Impact of Cyanocobalamin and Methylcobalamin on Inflammatory Bowel Disease and the Intestinal Microbiota Composition

被引:43
|
作者
Zhu, Xuan [1 ]
Xiang, Shasha [1 ]
Feng, Xiao [1 ]
Wang, Huanhuan [2 ]
Tian, Shiyi [1 ]
Xu, Yuanyuan [1 ]
Shi, Lihua [1 ]
Yang, Lu [2 ]
Li, Mian [3 ]
Shen, Yubiao [4 ]
Chen, Jie [1 ]
Chen, Yuewen [1 ]
Han, Jianzhong [1 ]
机构
[1] Zhejiang Gongshang Univ, Sch Food Sci & Bioengn, 18 Xuezheng St, Hangzhou 310018, Zhejiang, Peoples R China
[2] Hangzhou Normal Univ, Sch Med, Hangzhou 310018, Zhejiang, Peoples R China
[3] Zhejiang Huakang Pharmaceut Co Ltd, Quzhou 324302, Zhejiang, Peoples R China
[4] Tsinghua Univ, Yangtze Delta Reg Inst, Jiaxing 314000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cyanocobalamin; methylcobalamin; gut microbiome; inflammatory bowel disease; Enterobacteriaceae; VITAMIN-B-12; GUT; COLITIS; PATHOGENESIS; DEFICIENCY;
D O I
10.1021/acs.jafc.8b05730
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Patients with inflammatory bowel disease (IBD) are usually advised to supplement various types of vitamin B-12, because vitamin B-12 is generally absorbed in the colon. Thus, in the current study, the influence of cyanocobalamin (CNCBL) or methylcobalamin (MECBL) ingestion on IBD symptoms will be investigated. Then, whether and how the application of various cobalamins would modify the taxonomic and functional composition of the gut microbiome in mice will be examined carefully. Dextran-sulfate-sodium-induced IBD mice were treated with MECBL or CNCBL; disease activity index (DAI) scores and intestinal inflammatory conditions of mice were evaluated. Fecal samples were collected; microbiota composition was determined with a 16s rRNA analysis; functional profiles were predicted by phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt); and short-chain fatty acids were measured. The consequence of higher relative abundances of Enterobacteriaceae and isomeric short-chain fatty acids by cobalamin treatment revealed that a high concentration of CNCBL but not MECBL supplementation obviously aggravated IBD. A microbial ecosystem rich in Escherichia/Shigella and low in Lactobacillus, Blautia, and Clostridium XVIII was observed in IBD mice after a high concentration of CNCBL supplementation. In cobalamin-dependent enzymes, CNCBL was more efficient in the adenosylcobalamin system than MECBL and vice versa in the MECBL system. The distinct effects of various cobalamins were associated with the distribution and efficiency of vitamin-B-12-dependent riboswitches. CNCBL had a strong inhibitory effect on all riboswitches, especially on btuB and pocR riboswitches from Enterobacteriaceae. CNCBL aggravated IBD via enhancing the proportion of Enterobacteriaceae organisms through riboswitch and enzyme systems. The present study provides a critical reference for offering a suitable amount and type of cobalamin during a symbiotic condition.
引用
收藏
页码:916 / 926
页数:11
相关论文
共 50 条
  • [1] The intestinal microbiota and inflammatory bowel disease
    Guarner, Francisco
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (03): : 147 - 154
  • [2] The Intestinal Microbiota in Inflammatory Bowel Disease
    Becker, Christoph
    Neurath, Markus F.
    Wirtz, Stefan
    ILAR JOURNAL, 2015, 56 (02) : 192 - 204
  • [3] Inflammatory Bowel Disease and the Intestinal Microbiota
    Day, Andrew S.
    JOURNAL OF PEDIATRIC BIOCHEMISTRY, 2015, 5 (02) : 60 - 64
  • [4] The impact of exclusive enteral nutrition on the intestinal microbiota in inflammatory bowel disease
    Day, Andrew S.
    AIMS MICROBIOLOGY, 2018, 4 (04): : 584 - 593
  • [5] Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease
    Weingarden, Alexa R.
    Vaughn, Byron P.
    GUT MICROBES, 2017, 8 (03) : 238 - 252
  • [6] REDUCED ADHERENCE TO MEDITERRANEAN DIET AND INTESTINAL MICROBIOTA COMPOSITION IN INFLAMMATORY BOWEL DISEASE PATIENTS
    Altomare, A.
    Rocchi, G.
    Zorzi, F.
    Del Chierico, F.
    Lo Presti, A.
    Emerenziani, S.
    Nuglio, C.
    Pica, L.
    Ciccozzi, M.
    Putignani, L.
    Cicala, M.
    Guarino, M. P. L.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S130 - S131
  • [7] Intestinal microbiota in inflammatory bowel disease: Friend of foe?
    Fava, Francesca
    Danese, Silvio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05) : 557 - 566
  • [8] Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease
    Rok Orel
    Tina Kamhi Trop
    World Journal of Gastroenterology, 2014, (33) : 11505 - 11524
  • [9] Role of intestinal microbiota and metabolites in inflammatory bowel disease
    Dong Li-Na
    Wang Mu
    Guo Jian
    Wang Jun-Ping
    中华医学杂志英文版, 2019, 132 (13) : 1610 - 1614
  • [10] Role of intestinal microbiota and metabolites in inflammatory bowel disease
    Dong, Li-Na
    Wang, Mu
    Guo, Jian
    Wang, Jun-Ping
    CHINESE MEDICAL JOURNAL, 2019, 132 (13) : 1610 - 1614